spacer
home > pmps > summer 2019 > the long and the short of transdermal drug delivery
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Long and the Short of Transdermal Drug Delivery

For nearly 20 years, my career has been focused on the medical technology industry. While things have changed dramatically during that time in a variety of ways, I’ve discovered that this quote by the European writer Jean-Baptiste Alphonse Karr rings true: “Plus ça change, plus c’est la même chose”/ “The more things change, the more they stay the same”. While technology is changing the landscape in often unpredictable ways, the process for developing a new product and getting it to market remains all too predictable, and this takes a lot of time and a lot of resources.

Experience in this business is a key factor for success. At 3M Drug Delivery Systems (DDS), we have over 60 years in the inhalation business. From the formulation of a new idea during the R&D phase to the manufacturing and packing of the final product, 3M DDS draws upon experience to help support its partners at every point in their journey.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
At 3M, we apply science in collaborative ways to improve lives daily. With $33 billion in sales, our 93,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNews
spacer
Stephan Brakel
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

 
Industry Events

INTERPHEX 2020

28-30 April 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement